23andMe just got the OK to tell you if you have an increased risk of Alzheimer's, Parkinson's and other diseases
Lydia Ramsey/Business Insider
Up until now, 23andMe was able to provide health reports that showed whether you carried a variant for a genetic disease that could get passed down to your child, along with wellness reports that gave you information about caffeine consumption and lactose intolerance.
"Consumers can now have direct access to certain genetic risk information," Dr. Jeffrey Shuren, the FDA's director of the Center for Devices and Radiological Health said in a news release. "But it is important that people understand that genetic risk is just one piece of the bigger puzzle, it does not mean they will or won't ultimately develop a disease."
In November 2013, the FDA barred 23andMe from sending any of that data related to health to customers because of concerns that the company was misrepresenting genetic tests as medical advice.
On Thursday, the FDA said there are 10 tests 23andMe can include:
- Parkinson's disease
- Late-onset Alzheimer's disease
- Celiac disease
- Alpha-1 antitrypsin deficiency
- Early-onset primary dystonia
- Factor XI deficiency
- Gaucher disease type 1
- Glucose-6-Phosphate Dehydrogenase deficiency
- Hereditary hemochromatosis
- Hereditary thrombophilia
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- One of the world's only 5-star airlines seems to be considering asking business-class passengers to bring their own cutlery
- Vodafone Idea FPO allotment – How to check allotment, GMP and more
- Indians can now get multiple entry Schengen visa with longer validity as EU eases norms
- Investing Guide: Building an aggressive portfolio with Special Situation Funds
- Markets climb in early trade on firm global trends; extend winning momentum to 3rd day running
- Impact of AI on Art and Creativity
- Reliance Industries quarterly profit stays flat; annual earnings hit record at ₹69,621 crore